PART I . Overview Our Business We are a cell therapy company focused on immunotherapy. Since our inception, we have been involved with the development of proprietary immune system management technology (Cell Source technology) licensed from Yeda Research & Development Company Limited (Yeda), the commercial arm of the Weizmann Institute of Science (Weizmann Institute) in Israel. The current focus of our Research and Development efforts is at the University of Texas MD Anderson Cancer Center (MD A...
Q2 FY2026 — expected 2026-07-22
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-06-24 | 2023-12-31 | 0001493152-24-024903 | EDGAR | 78K words |
| 2023-08-08 | 2022-12-31 | 0001493152-23-027069 | EDGAR | — |
| 2022-04-15 | 2021-12-31 | 0001493152-22-010133 | EDGAR | — |
| 2021-04-15 | 2020-12-31 | 0001640334-21-000923 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001640334-20-000672 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001165527-19-000034 | EDGAR | — |
| 2018-07-25 | 2017-12-31 | 0001165527-18-000154 | EDGAR | — |
| 2016-04-14 | 2015-12-31 | 0001165527-16-000733 | EDGAR | — |
| 2015-03-13 | 2014-12-31 | 0001144204-15-015954 | EDGAR | — |
| 2014-03-25 | 2013-12-31 | 0001165527-14-000161 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-11-14 | 2024-09-30 | 0001493152-24-045964 | EDGAR | 23K words |
| 2024-08-19 | 2024-06-30 | 0001493152-24-033055 | EDGAR | — |
| 2024-07-29 | 2024-03-31 | 0001493152-24-029448 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001493152-23-040079 | EDGAR | — |
| 2023-09-19 | 2023-06-30 | 0001493152-23-033011 | EDGAR | — |
| 2023-08-23 | 2023-03-31 | 0001493152-23-029915 | EDGAR | — |
| 2022-12-08 | 2022-09-30 | 0001493152-22-034876 | EDGAR | — |
| 2022-12-02 | 2022-06-30 | 0001493152-22-034255 | EDGAR | — |
| 2022-11-02 | 2022-03-31 | 0001493152-22-030233 | EDGAR | — |
| 2021-11-15 | 2021-09-30 | 0001493152-21-028675 | EDGAR | — |
| 2021-08-12 | 2021-06-30 | 0001493152-21-019491 | EDGAR | — |
| 2021-05-17 | 2021-03-31 | 0001493152-21-011971 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-06-27 | 0001641172-25-016833 | EDGAR | 1K words |
| 2024-04-09 | 0001493152-24-014035 | EDGAR | — |
| 2022-07-21 | 0001493152-22-019997 | EDGAR | — |
| 2022-05-06 | 0001493152-22-012387 | EDGAR | — |
| 2022-03-11 | 0001493152-22-006672 | EDGAR | — |
| 2021-04-02 | 0001640334-21-000755 | EDGAR | — |
| 2019-04-19 | 0001165527-19-000053 | EDGAR | — |
| 2015-11-16 | 0001165527-15-000545 | EDGAR | — |
| 2015-11-05 | 0001165527-15-000524 | EDGAR | — |
| 2015-08-19 | 0001165527-15-000418 | EDGAR | — |
75 total filings indexed. 43 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001569340 |
| Ticker | CLCS |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CLCS (~200 tokens, structured JSON with cryptographic provenance)